Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01530009 · ClinicalTrials.gov registry record · NA
The Effect of Amoxicillin Versus Placebo on Gastrointestinal Motility in Children
A NA study, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT01530009 is a NA study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 33 participants.
The verdict
NCT01530009, a NA study, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether amoxicillin (AMX) alone has an appreciable effect on upper gastrointestinal motility compared to placebo. In particular, induction of phase III of the interdigestive migrating motor complex (MMC) by AMX will be the primary outcome of the study. MMCs are periodic waves of electrical activity resulting in muscular contractions that pass through the walls of the stomach and intestinal tract during the fasting state. It is characterized by an initial period where there is a minimal electrical activity and muscular contraction (phase I), followed by a gradual increase in the frequency of contractions (phase III) that often leads to a characteristic cluster of contractions (phase III). This cycle occurs only in the fasting state in normal individuals and the frequency of phase III is quite varied, dependent on age and the presence of any underlying abnormalities in gastrointestinal motility. Secondary outcomes will include characteristics of the MMC, patient demographics in responders and non-responders, and the safety profile of AMX at the intervention dose.
Interventions
- OTHER Placebo
- DRUG Amoxicillin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2012-01 |
| Est. Completion | 2022-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01530009
The ClinicalTrials.gov registry entry for NCT01530009 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01530009 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01530009 about?
NCT01530009 is a clinical study titled "The Effect of Amoxicillin Versus Placebo on Gastrointestinal Motility in Children". The goal of this study is to determine whether amoxicillin (AMX) alone has an appreciable effect on upper gastrointestinal motility compared to placebo. In particular, induction of phase III of the interdigestive migrating motor complex (MMC) by AMX will be the primary outcome of the study. MMCs are...
What is the current status of trial NCT01530009?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2012-01. Estimated completion is 2022-01.
What interventions are being tested in trial NCT01530009?
The interventions under investigation include: Placebo (OTHER), Amoxicillin (DRUG).
Who is sponsoring clinical trial NCT01530009?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.